|
|
Article: Aldara (Imiquimod) Cream, 5% Included in Multiple Poster Presentations at American Academy of Dermatology's ACADEMY 06 Meeting.
- Article from:
- Business Wire
- Article date:
- July 27, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ST. PAUL, Minn. -- Aldara is First and Only Immune Response Modifier Indicated for the Treatment of Actinic Keratosis, Superficial Basal Cell Carcinoma and External Genital and Perianal Warts
3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology's (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external genital and perianal warts. The prescription therapy works by stimulating the skin's immune response to clear ...